News

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2021.

Fourth Quarter Highlights

• 
  Revenue totaled $593.5

Novocure (NASDAQ: NVCR) today announced that Todd Longsworth, General Counsel, has resigned. Mr. Longsworth’s last day as General Counsel will be March 31. He will stay onboard as a Senior Legal

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Novocure (NASDAQ: NVCR) today announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption

Novocure (NASDAQ: NVCR) today reported financial results for the fourth quarter and full year ended December 31, 2021. Novocure is a global oncology company working to extend survival in some of

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported financial

Cole Edmonson, Chief Clinical Officer of AMN Healthcare (NYSE: AMN), has been honored as one of Staffing Industry Analysts’ 2022 Staffing 100, the leaders of the staffing industry.

The Staffing

AMN Healthcare, the nation’s leader in total talent solutions for healthcare, today announced the 2021 MSP Supplier Partnership Award winners who help provide quality professionals to AMN Managed

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company’s capital stock, payable on March 18, 2022, to

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2021 results on Monday, February 28, 2022, after the close of the market. Acadia

AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced it was named among America’s Best Employers for 2022

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2021 and reaffirmed guidance for 2022. For the quarter, revenue was $905.1

Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, announced today that members of its management team are scheduled to participate in a virtual fireside chat

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been awarded the 2022 Best in KLAS designation for Value-Based Care Consulting. The award was announced in

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2021, on Thursday, February 24, 2022, following the close of trading

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced

For the third year in a row, AMN Healthcare (NYSE: AMN) has been named one of the country’s most responsible companies by Newsweek and Statista Action for its commitment and action to promote

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 second quarter ended December 31, 2021.

"Our

AMN Healthcare’s commitment to diversity, equity, equality, and inclusion has again been recognized in the business world with the company’s listing in two top corporate indexes that measure

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership

In line with its commitment to the health and wellbeing of nurses, and for advancing diversity, equality, equity, and inclusion in the nursing profession, AMN Healthcare is donating to support the

AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2021 financial results and first quarter 2022 outlook on Thursday, February

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.20 per share of Class A common